{"nctId":"NCT04819776","briefTitle":"Evaluation of Efficacy and Safety of Iloperidone in the Acute Treatment of Manic or Mixed Episodes Associated With Bipolar I Disorder","startDateStruct":{"date":"2021-03-22","type":"ACTUAL"},"conditions":["Bipolar I Disorder"],"count":417,"armGroups":[{"label":"Iloperidone","type":"EXPERIMENTAL","interventionNames":["Drug: Iloperidone"]},{"label":"Placebo","type":"PLACEBO_COMPARATOR","interventionNames":["Drug: Iloperidone Placebo"]}],"interventions":[{"name":"Iloperidone","otherNames":["FANAPTÂ®","VYV-683"]},{"name":"Iloperidone Placebo","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Male or female patients 18 to 65 years of age (inclusive)\n* Diagnosed with bipolar I disorder, manic or mixed-type, per DSM-5 criteria\n* Voluntary hospitalization for current manic episode\n\nExclusion Criteria:\n\n* Patients with a DSM-5 diagnosis of a psychiatric disorder other than bipolar I disorder that was the primary focus of treatment within the previous six months\n* Patients who are experiencing a first manic episode or meeting criteria for rapid cycling","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","maximumAge":"65 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Change From Baseline to Week 4 in Young Mania Rating Scale (YMRS) Total Score","description":"The Young Mania Rating Scale (YMRS) is an 11-item scale. Individual item scores are summed for a total possible score of 0 (best) to 60 (worst).","paramType":"MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-14.0","spread":"0.64"},{"groupId":"OG001","value":"-10.0","spread":"0.63"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":4,"n":206},"commonTop":["Tachycardia","Dizziness","Dry mouth","Alanine aminotransferase increased","Nasal congestion"]}}}